An association between the Trp64Arg polymorphism in the β3-adrenergic receptor gene and endometrial cancer and obesity

Journal of Experimental and Clinical Cancer Research

Volumn 23, Issue 4, 2004, Pages 669-674

  Babol, K ^a   Przybylowska, K ^a   Lukaszek, M ^b   Pertynski, T ^b   Blasiak, Janusz ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

3 adrenergic receptor; Endometrial cancer; Genetic polymorphism; Obesity; Overweight

Indexed keywords

ARGININE; BETA 3 ADRENERGIC RECEPTOR; TRYPTOPHAN;

ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CANCER; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; HUMAN CELL; INSULIN RESISTANCE; LIPOLYSIS; MAJOR CLINICAL STUDY; MSP1 GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL SIGNIFICANCE;

ADIPOSE TISSUE; ADULT; AGED; ALLELES; ARGININE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DNA; DNA RESTRICTION ENZYMES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOMETRIAL NEOPLASMS; FEMALE; GENOTYPE; HUMANS; INSULIN RESISTANCE; LEUKOCYTES; LOGISTIC MODELS; MIDDLE AGED; OBESITY; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POSTMENOPAUSE; PREMENOPAUSE; RECEPTORS, ADRENERGIC, BETA-3; TRYPTOPHAN;

EID: 12544258186     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Shu X.O., Brinton L.A., Zheng W., Swanson C.A., Hatch M.C., Gao Y.T., Fraumeni J. F. Jr.: Relation of obesity and body fat distribution to endometrial cancer in Shanghai, China. Cancer Res. 52: 3865-3869, 1992.
2. Kaye S.A., Folsom A.R., Soler J.T., Prineas R.J., Potter J.D.: Associations of body mass and fat distribution with sex hormone concentrations in post-menopausal women. Int. J. Epidemiol. 20: 151-156, 1991.
3. Wolna M., Kedzia H., Pisarski T. In: Pisarski T (ed) Poloznictwo i ginekologia, Panstwowy Zaklad Wydawnictw Lekarskich, Warsaw, pp. 476-483, 1993.
4. Grady D., Ernster V.L., Schottenfeld D., Fraumeni J.F.: eds. Cancer Epidemiology and Prevention, Oxford Press New York 725-771, 1996.
5. McPherson C.P., Sellers T.A., Potter J.D., Bostick R.M., Folsom A.R.: Reproductive factors and risk of endometrial cancer: The Iowa Women's Health Study. Am. J. Epidemiol. 143: 1195-1202, 1996.
6. Brinton L.A., Berman M.L., Mortel R., Twiggs L.B., Barrett R.J., Wilbanks G.D., Lannom L., Hoover R.: Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study. Am. J. Obstet. Gynecol. 167: 1317-1325, 1992.
7. Gray L.A., Christopherson W.N., Hoover R.N.: Estrogens and endometrial carcinoma. Obstet. Gynecol. 49: 385, 1977.
8. Wynder E.L., Escher G.C., Mantel N.: An epidemiological investigation of cancer of the endometrium. Cancer 19: 489, 1966.
9. Fox H., Buckley C.H.: The endometrial hyperplasias and their relationship to endometrial neoplasia. Histopathology 6: 493, 1982.
10. Potischman N., Hoover R.N., Brinton L., Siiteri P., Dorgan J.F., Swanson C.A., Berman M.L., Mortel R., Twiggs L.B., Barrett R.J., Wilbanks G.D., Persky V., Lurain J.R.: A case-control study of endogenous steroid hormones and endometrial cancer. J. Natl. Cancer Inst. (Bethesda) 88: 1127-1135, 1996.
11. Mack T.M. et al.: Estrogens and endometrial cancer in a retirement community. N. Engl. J. Med. 294: 1262, 1976.
12. Barbieri R.L., Smith S., Ryan K.J.: The role of hyper-insulinemia in the pathogenesis of ovarian hyperandrogenism. Fertil. Steril. 50: 197-212, 1988.
13. Swanson C.A., Potischman N., Wilbanks G.D., Twiggs L., Mortel R., Berman M.L., Barrett R.J., Baumgartner R.N., Brinton L.A.: Relation of endometrial cancer risk to past and contemporary body size and body fat distribution. Cancer Epidemiol. Biomark Prev. 2: 321-327, 1993.
14. Folsom A.R., Kaye S.A., Potter J.D., Prineas R.J.: Association of incident carcinoma of the endometrium with body weight and fat distribution in older women: early findings of the Iowa Women's Health Study. Cancer Res. 49: 6828-6831, 1989.
15. Parazzini F., La Vecchia C., Bocciolone L., Francheschi S.: The epidemiology of endometrial cancer. Gynecol. Oncol. 41: 1-16, 1991.
16. Nyholm H., Djursing H., Hagen C., Agner T., Bennett P., Svenstrup B.: Androgens and estrogens in postmenopausal insulin-treated diabetic women. J. Clin. Endocrinol. Metab. 69: 946-949, 1989.
17. Anderson K.E., Anderson E., Mink P.J., Ping Hong C., Kushi L.H., Sellers T.A., Lazovich D.A. and Folsom A.R.: Diabetes and Endometrial Cancer in the Iowa Women's Health Study. Cancer Epidemiol. Biomarkers Prev. 10:611-616, 2001.
18. 3-adrenergic receptor mutations to insulin resistance and obesity respectively with no evidence for glicogen syntethase gene mutations. Diabetologia 39: 1505-1511, 1996.
19. 3-adrenergic receptor gene with NIDDM, current and maximal body mass index. Diabetologia 39: 1410-1411, 1996.
20. 3- adrenergic receptor gene Trp/Arg mutation is overrepresented in obese women. Diabetes 45: 1358-1363, 1996.
21. 3-adrenergic receptor gene with coronary heart disease among Japanese. Biochem. Biophys. Res. Commun. 323: 728-730, 1997.
22. 3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem. Biophys. Res. Commun. 215: 555-560, 1995.
23. 3-adrenergic receptor is associated with visceral obesity but decreased serum triglyceride. Diabetologia 40: 469-472, 1997.
24. 3- adrenergic receptor gene. N. Engl. J. Med. 333: 343-347, 1995.
25. 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N. Engl. J. Med. 333:352-354, 1995.
26. 3-adrenergic receptor gene in morbid obesity. Int. J. Obesity 20: 1055-1061, 1996.
27. 3- adrenergic receptor gene or weight gain in morbid obesity. Int. J. Obesity 20: 1062-1066, 1996.
28. Nonogaki K.: New insights into sympathetic regulation of glucose and fat metabolism. Diabetologia 43: 533-549, 2000.
29. 3-adrenergic receptor gene with features of the insulin resistance syndrome in Finns. N. Engl. J. Med. 333: 348-351, 1995.
30. 3-adrenergic receptor with NIDDM and body weight gain. Diabetologia 39: 349-352, 1996.
31. 3- adrenergic receptor Japanese NIDDM patients. Diabetes Care 19: 271-272, 1996.
32. 3-adrenergic receptor gene. Diabetologia 20: 1329-1323, 1997.